Brian Varnum
Plus aucun poste en cours
Fortune : 98 605 $ au 30/04/2024
Historique de carrière de Brian Varnum
Anciens postes connus de Brian Varnum
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/08/2021 | 11/07/2023 |
| Directeur Général | 02/08/2021 | 11/07/2023 | |
| President | 09/05/2019 | 02/08/2021 | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01/03/2012 | 01/05/2019 |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01/01/2012 | - |
Formation de Brian Varnum
| University of California | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
- Bourse
- Insiders
- Brian Varnum
- Expérience
